Assessment of cannabinoid induced gene changes: tolerance and neuroprotection.
about
The endocannabinoid system in normal and pathological brain ageingDiffusion abnormalities in adolescents and young adults with a history of heavy cannabis useMolecular model of cannabis sensitivity in developing neuronal circuitsThe endocannabinoid system as an emerging target of pharmacotherapyNrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout miceIn vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid systemCannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell deathNeuronal substrates and functional consequences of prenatal cannabis exposure.Increases in expression of 14-3-3 eta and 14-3-3 zeta transcripts during neuroprotection induced by delta9-tetrahydrocannabinol in AF5 cells.Altered white matter microstructure in adolescent substance users.Cannabis and development of dual diagnoses: A literature review.Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure.Associations between adolescent cannabis use and brain structure in psychosis.Cerebellar white-matter changes in cannabis users with and without schizophrenia
P2860
Q22242668-519CABA0-4734-4739-9C07-884A89CB8D2CQ24608718-D486639C-B109-4054-9D3B-B5C3ECDDBF36Q24613715-3AF0E126-D4AA-49A6-BB0D-A6334CB80A9DQ24648473-8861E6D2-D243-4DEC-98A7-B699B7A64127Q28269117-34C9CC77-D711-48CC-8C96-3A64B2CEABEEQ28570135-28C54BE9-D9F4-4BD3-9620-DFB926F644C1Q31095554-37C49964-F8F4-4E49-BE25-4172316CFD0BQ35682377-871A5F49-CB85-4DB8-B756-90C0EC1F1290Q35694094-8726ED0C-E7C6-4A77-99B4-A05D7CE133CEQ36726916-63C9CB49-79DC-42FC-8F6C-87E837929228Q37325687-83FACAD1-02D6-42C9-9CA4-556834629DE0Q38950359-6C0CB338-31EE-4505-94AC-608E4B532EEEQ48131076-5BC248FF-8D55-461A-8292-AB44831879CFQ52600030-439DAE5A-B700-466C-8075-6AC763DBD011Q57736864-46F4227B-A5D9-4BC9-B47F-2A65ACE4EE8C
P2860
Assessment of cannabinoid induced gene changes: tolerance and neuroprotection.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Assessment of cannabinoid induced gene changes: tolerance and neuroprotection.
@ast
Assessment of cannabinoid induced gene changes: tolerance and neuroprotection.
@en
type
label
Assessment of cannabinoid induced gene changes: tolerance and neuroprotection.
@ast
Assessment of cannabinoid induced gene changes: tolerance and neuroprotection.
@en
prefLabel
Assessment of cannabinoid induced gene changes: tolerance and neuroprotection.
@ast
Assessment of cannabinoid induced gene changes: tolerance and neuroprotection.
@en
P2093
P50
P1476
Assessment of cannabinoid induced gene changes: tolerance and neuroprotection
@en
P2093
Andrew Boon
Chris Clayton
Clair Pagget
Don Wallace
Elena Grigorenko
Gavin Lowe
Sam Deadwyler
Sarah Bundey
Seiji Hayashizaki
ShouYuan Zhuang
P304
P356
10.1016/S0009-3084(02)00161-5
P577
2002-12-01T00:00:00Z